Good news about the treatment of Alzheimer’s disease is hard to find. However, new breakthrough research is hailed as the “best news” in dementia research for 25 years and a potential “game changer” for people with the disease. In a preliminary trial a bioengineered medication called aducanumab has demonstrated the ability to clear accumulations of beta-amyloid proteins—a hallmark of Alzheimer’s—from the brain. Compared with subjects receiving a placebo medication, those who got monthly infusions of aducanumab in high doses appeared to experience less progressive loss in mental function.
Experimental drug slows memory loss and halts Alzheimer’s decline
More of Today's Solutions
How Paraguay cut its poverty rate from over 50 to 16 percent in two decades
BY THE OPTIMIST DAILY EDITORIAL TEAM In 2005, more than half of Paraguay’s population lived in poverty. By 2025, that share had fallen to ...
Read MorePro parenting tips to spark your children’s life-long love for the grea...
BY THE OPTIMIST DAILY EDITORIAL TEAM In today's digital world, the pull of screens can be difficult to overcome, particularly for kids. However, the ...
Read MoreRainforest nations join forces to protect biodiversity
Late last month, major rainforest nations gathered in Brazzaville, Republic of Congo, to address the rising problem of deforestation and safeguard the invaluable biodiversity ...
Read MoreInvestigating when our bodies change the fastest and why it matters
BY THE OPTIMIST DAILY EDITORIAL TEAM Aging might seem like a slow, steady march, but science suggests otherwise. If you’ve ever looked in the ...
Read More
